We propose the hypothesis that the current body of evidence is consistent with a prevention-focused model, wherein semaglutides primary value may lie in modifying the upstream metabolic and inflammatory drivers of neurodegeneration, such as those prevalent in vascular and metabolic cognitive impairment, rather than reversing established amyloid-driven AD pathology
Continuing treatment produces additional weight loss and sustained results
Sources Benson, K., Flory, K., Humphreys, K
Johns Wort and CYP enzyme interactions As discussed previously, CYP enzymes are key in breaking down tamoxifen into its active form endoxifen
lysyl oxidase-like 2 (LOXL2), 17 which involves in fibrosis
Reduced Food Obsession Individuals using tirzepatide often experience a substantial decrease in food cravings and persistent thoughts about eating, allowing them to focus on other aspects of their life